PuriCore plc is Currently Managed by Michael Ashton

Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) announces submitting Rule LR 9.6.14. According to this rule Hikma must notify the market when directors of Hikma become directors of other publicly traded companies. Mr. Michael Ashton, an independent non-executive director of Hikma became an independent non-executive director of PuriCore plc (LSE: PURI) with effect from 1 February 2012.

“PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercializing proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCore‘s patented, proprietary technology offers a safe and non-hazardous approach to disinfection and sanitization” Source: PuriCore plc.